11 Jul 2011

C.difficile: MERIDIAN BIOSCIENCE 1-hour test

NB:Provincial lab closed at week-ends and Holidays.

 

Clostridium difficile (C. difficile or C. diff) and methicillin-resistant Staphylococcus aureas (MRSA) are the leading causes of nosocomial infection.1 C. diff is an opportune pathogen, affecting primarily the elderly and the immunocompromised. Currently more than 500,000 cases of C. difficile infection (CDI) are diagnosed each year in the U.S.2 In the U.S between 1999 and 2004, mortality from CDI increased from 5.7 deaths per million people to 23.7 per million.3


Current information on C. difficile disease and increasing prevalence and virulence
 

Selected Articles

Rising case rates and mortality documented for C. difficile colitis. Medpage Today
Clostridium difficile infection in hospitals: a brewing storm. Canadian Med Assoc J.
Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol.

1 comment:

  1. AnonymousJuly 11, 2011

    Meridian Bioscience produces`ILLUMIGENE ASSAY.
    1-hour test.

    ReplyDelete